Paramount BioCapital Asset Management

Paramount BioCapital Asset Management

A venture capital and private equity firm investing in pharmaceutical and healthcare companies.

All edits

Edits on 4 Feb, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 4 Feb, 2020
Edits made to:
Article (+34/-34 characters)
Article

As of December 2019, Paramount BioCapital Asset Management has made 4 investments, 1 lead investment, and 4 exits. Notable investments made by Paramount BioCapital Asset Management include: CEL-SCI, Innovive Pharmaceuticals, Genelabs Technologies, and Chelsea Therapeutics InternationalChelsea Therapeutics International.

Edits on 31 Jan, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 31 Jan, 2020
Edits made to:
Article (+21/-21 characters)
Article

As of December 2019, Paramount BioCapital Asset Management has made 4 investments, 1 lead investment, and 4 exits. Notable investments made by Paramount BioCapital Asset Management include: CEL-SCI, Innovive Pharmaceuticals, Genelabs TechnologiesGenelabs Technologies, and Chelsea Therapeutics International.

Edits on 30 Jan, 2020
Carla Faraguna
Carla Faraguna edited on 30 Jan, 2020
Edits made to:
Article (+2/-28 characters)
Article

According to Crunchbase (asAs of December 2019), Paramount BioCapital Asset Management has made 4 investments, 1 lead investment, and 4 exits. Notable investments made by Paramount BioCapital Asset Management include: CEL-SCI, Innovive Pharmaceuticals, Genelabs Technologies, and Chelsea Therapeutics International.

Edits on 15 Dec, 2019
Dawson Sewell
Dawson Sewell edited on 15 Dec, 2019
Edits made to:
Infobox (+1/--1 properties)
Description (+96 characters)
Article (+625 characters)
Topic thumbnail

Paramount BioCapital Asset Management

A venture capital and private equity firm investing in pharmaceutical and healthcare companies.

Article

Paramount BioCapital Asset Management is a venture capital and private equity firm investing in pharmaceutical and healthcare companies that is headquartered in New York City, New York. The firms website is no longer active suggesting Paramount BioCapital Asset Management is no longer in business.

Investments

According to Crunchbase (as of December 2019), Paramount BioCapital Asset Management has made 4 investments, 1 lead investment, and 4 exits. Notable investments made by Paramount BioCapital Asset Management include: CEL-SCI, Innovive Pharmaceuticals, Genelabs Technologies, and Chelsea Therapeutics International.

Infobox
Location
New York City
Company status
Closed
Edits on 11 Jul, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 11 Jul, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Is a
Company
Edits on 9 Jul, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 9 Jul, 2019
Edits made to:
Infobox (+3 properties)
Infobox
Is a
Venture capital firm
Golden AI"Initial topic creation"
Golden AI created this topic on 9 Jul, 2019
Edits made to:
Topic thumbnail

 Paramount BioCapital Asset Management

A venture capital and private equity firm investing in pharmaceutical and healthcare companies.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.